SCHEMBL4669491

SCHEMBL4669491

CCc1cccc(-c2cc(N)n(-c3ncccc3C(F)(F)F)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 2/20 0.43
NFKB1 P19838 2/20 0.43
RAB9A P51151 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
HSD11B1 P28845 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NTRK1 P04629 1/20 0.37
AXL P30530 1/20 0.36
BACE1 P56817 1/20 0.36
IDO1 P14902 1/20 0.36
KDM4E B2RXH2 1/20 0.36
EPHX2 P34913 1/20 0.35
ATM Q13315 1/20 0.35
CYP17A1 P05093 1/20 0.35
OPRL1 P41146 1/20 0.35
P2RX7 Q99572 1/20 0.35
CAPN1 P07384 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668551 0.84 SMN1; SMN2 (0.46) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL14600999 0.76 FABP4 (0.44) NTRK1CAPN1NR1H2NR1H3
SCHEMBL14600998 0.74 DHODH (0.46) NTRK1LMNA
SCHEMBL14600469 0.74 NTRK1 (0.44) NTRK1P2RX7CAPN1
SCHEMBL4666864 0.74 SMN1; SMN2 (0.45) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL14601001 0.74 NTRK1 (0.40) L3MBTL1NTRK1KDM4EP2RX7CAPN1
SCHEMBL14601002 0.74 MPO (0.40) NTRK1CAPN1MEN1LMNAKMT2A
SCHEMBL4667077 0.73 NTRK1 (0.38) HSD11B1ALDH1A1NTRK1CAPN1LMNA
SCHEMBL14601000 0.73 IGF2BP2 (0.39) NTRK1
SCHEMBL4667857 0.71 DHODH (0.42) NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed